Anixa Biosciences, Inc.
ANIX · NASDAQ
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,698 | -$9,930 | -$13,771 | -$13,128 |
| Dep. & Amort. | $37 | $46 | $42 | $60 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,420 | $4,422 | $6,000 | $7,503 |
| Change in WC | $526 | -$1,060 | $485 | $79 |
| Other Non-Cash | $380 | $313 | $752 | -$5 |
| Operating Cash Flow | -$7,335 | -$6,209 | -$6,492 | -$4,937 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $6 |
| Inv. Purchases | -$63,770 | -$44,411 | -$22,486 | -$16,499 |
| Inv. Sales/Matur. | $68,046 | $38,809 | $11,758 | $12,539 |
| Other Inv. Act. | $0 | $0 | -$10,728 | $35 |
| Investing Cash Flow | $4,276 | -$5,602 | -$10,728 | -$3,918 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,955 | $92 | $97 | $31,126 |
| Stock Repurch. | -$6 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $466 | $366 | $452 | $440 |
| Financing Cash Flow | $3,415 | $366 | $452 | $31,566 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $356 | -$11,445 | -$16,768 | $22,711 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $915 | $12,360 | $29,128 | $6,417 |
| End Cash | $1,271 | $915 | $12,360 | $29,128 |
| Free Cash Flow | -$7,335 | -$6,209 | -$6,492 | -$4,937 |